Metformin Aurobindo

Metformin Hydrochloride, the active ingredient in Metformin Aurobindo, is a biguanide presented as an oral tablet for oral use. It lowers elevated blood glucose levels and is indicated for the management of type 2 diabetes mellitus in adult patients.

GNH USA supplies Metformin Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for import and distribution. Its global network enables reliable delivery to diverse healthcare settings across the European Union and beyond.

Metformin Aurobindo, a biguanide antidiabetic agent, is employed to improve glucose metabolism in several related conditions.

- Type 2 diabetes mellitus: improves glycemic control by lowering fasting and post‑prandial blood glucose. - Prediabetes (impaired glucose tolerance): helps delay progression to overt type 2 diabetes when combined with lifestyle measures. - Polycystic ovary syndrome: reduces insulin resistance and may aid in menstrual regularity.

Metformin Aurobindo may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea. - Metallic taste: transient alteration in taste perception. - Vitamin B12 deficiency: reduced absorption with long‑term use. - Weight loss: modest decrease in body weight.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycemia: usually when combined with insulin or sulfonylureas. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

When prescribing Metformin Aurobindo, several precautions should be observed to ensure patient safety.

- Renal function assessment: evaluate creatinine clearance before initiation and periodically. - Contraindication in severe renal impairment: avoid use if eGFR <30 mL/min/1.73 m². - Monitor for lactic acidosis: watch for unexplained acidosis, especially after surgery or in hypoxic states. - Vitamin B12 monitoring: consider periodic testing during long‑term therapy. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Metformin Aurobindo can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated radiographic contrast media: can precipitate acute renal failure and increase risk of lactic acidosis; discontinue metformin before and after the procedure. - Renal‑toxic drugs (e.g., aminoglycosides, NSAIDs): may impair renal function, raising metformin concentrations.

Moderate Interactions (Monitor Closely): - Sulfonylureas or insulin: additive hypoglycaemic effect; monitor blood glucose closely. - Cimetidine or other CYP450 inhibitors: may increase metformin plasma levels. - Oral corticosteroids: may elevate blood glucose, requiring possible dose adjustment.